Bernard Lim
Chief Operating Officer chez CARDIOL THERAPEUTICS INC.
Fortune : 54 300 $ au 31/03/2024
Profil
Bernard Lim is currently the Chairman & Chief Executive Officer at Anders Electronics Plc since 2014.
He is also the Chairman at Acuity Insights, Inc. since 2015, the Chairman at Front Line Medical Technologies Inc since 2020, the Director at Selectronic Ltd., and a Non-Executive Director at Aventamed DAC.
Additionally, he holds the position of Chief Operating Officer at Cardiol Therapeutics, Inc. since 2020.
In his former positions, Mr. Lim served as the Chief Executive Officer at Mirae Asset Global Investment Management (Asia) Pte Ltd.
He was also an Investment Director at Congruix Investment Management from 2001 to 2007, and a Senior Vice President-Operations at Vasogen, Inc. during the same period.
Furthermore, he worked as a Senior Fund Manager at Threadneedle Investments Singapore (Pte) Ltd.
from 2013 to 2017.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/02/2024 | 30 000 ( 0,05% ) | 54 300 $ | 31/03/2024 |
Postes actifs de Bernard Lim
| Sociétés | Poste | Début |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Chief Operating Officer | 03/12/2020 |
Anders Electronics Plc
 Anders Electronics Plc Electronics DistributorsDistribution Services Anders Electronics Plc engages in wholesale of electronic and telecommunications equipment and parts. It offers display solutions, embedded solutions, and design services. The company was founded in 1952 and is headquartered in London, the United Kingdom. | Chief Executive Officer | 01/01/2014 |
Selectronic Ltd.
 Selectronic Ltd. Electronic Production EquipmentElectronic Technology Selectronic Ltd. manufactures and distributes TFT displays, LED custom display lighting, touch panels, PCB modules, LED lighting and other related products. The company was founded in 1979 and is headquartered in Oxfordshire, the United Kingdom. | Director/Board Member | 10/03/2020 |
Aventamed DAC
 Aventamed DAC Medical SpecialtiesHealth Technology Aventamed DAC manufactures medical devices for surgeries. The company was founded by Olive O''Driscoll and John Vaughan and is headquartered in Bishopstown, Ireland. | Director/Board Member | - |
Acuity Insights, Inc.
 Acuity Insights, Inc. Other Consumer ServicesConsumer Services Acuity Insights, Inc. provides educational services. The company was founded by Rich Emrich, Kelly Dore, and Harold Reiter in September 2014 and is headquartered in Toronto, Canada. | Chairman | 01/01/2015 |
| Front Line Medical Technologies Inc | Chairman | 01/01/2020 |
Anciens postes connus de Bernard Lim
| Sociétés | Poste | Fin |
|---|---|---|
Threadneedle Investments Singapore (Pte) Ltd.
 Threadneedle Investments Singapore (Pte) Ltd. Investment ManagersFinance Threadneedle Investments Singapore (Pte) Ltd. is an investment management firm headquartered in Singapore. They are a subsidiary of Threadneedle Asset Management Holdings Ltd., ultimately owned by Ameriprise Financial, Inc. (NYSE: AMP) in the US. The firm provides a broad range of actively managed investment strategies and solutions for individual, institutional and corporate clients in Asia. | Analyst-Equity | 01/01/2017 |
Congruix Investment Management
 Congruix Investment Management Investment ManagersFinance Congruix Investment Management, formerly known as Legg Mason International Equities (Singapore), is the investment management division within Legg Mason International Equities (Singapore) Pte Ltd. which is a wholly-owned subsidiary of the Baltimore-based financial services holding company Legg Mason, Inc. (NYSE: LM). Congruix originated as Legg Mason Asset Management Asia and has been managing collective investment schemes in Singapore since 1995. Through a series of joint ventures and acquisitions, the firm has integrated Singaporean investment arms of Western Asset, Batterymarch and Rothschild Asset Management. Congruix manages and sub-advises Asia Pacific equities and mandates on behalf of institutions and retail investors, either as separate accounts or through unit trusts. Their fellow division Legg Mason Investments distributes Legg Mason's Singapore-domiciled unit trusts and Legg Mason's Luxembourg- and Dublin-domiciled mutual fund ranges. | Director of Investments | 04/04/2007 |
Vasogen, Inc.
 Vasogen, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are research and commercialization of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. It's lead product, the Celacade System, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade has received European regulatory approval under the CE Mark for chronic heart failure and is currently being marketed in Europe by Grupo Ferrer Internacional, S.A. Celacade is also in late-stage development for the treatment of chronic heart failure in the United States. It is also developing a new class of drugs for the treatment of certain neuro-inflammatory disorders. VP025 is the lead drug candidate from this new class. | Chief Operating Officer | 01/01/2007 |
| ░░░░░ ░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CARDIOL THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are research and commercialization of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. It's lead product, the Celacade System, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade has received European regulatory approval under the CE Mark for chronic heart failure and is currently being marketed in Europe by Grupo Ferrer Internacional, S.A. Celacade is also in late-stage development for the treatment of chronic heart failure in the United States. It is also developing a new class of drugs for the treatment of certain neuro-inflammatory disorders. VP025 is the lead drug candidate from this new class. | Health Technology |
Congruix Investment Management
Congruix Investment Management Investment ManagersFinance Congruix Investment Management, formerly known as Legg Mason International Equities (Singapore), is the investment management division within Legg Mason International Equities (Singapore) Pte Ltd. which is a wholly-owned subsidiary of the Baltimore-based financial services holding company Legg Mason, Inc. (NYSE: LM). Congruix originated as Legg Mason Asset Management Asia and has been managing collective investment schemes in Singapore since 1995. Through a series of joint ventures and acquisitions, the firm has integrated Singaporean investment arms of Western Asset, Batterymarch and Rothschild Asset Management. Congruix manages and sub-advises Asia Pacific equities and mandates on behalf of institutions and retail investors, either as separate accounts or through unit trusts. Their fellow division Legg Mason Investments distributes Legg Mason's Singapore-domiciled unit trusts and Legg Mason's Luxembourg- and Dublin-domiciled mutual fund ranges. | Finance |
| Mirae Asset Global Investment Management (Asia) Pte Ltd. | |
Anders Electronics Plc
Anders Electronics Plc Electronics DistributorsDistribution Services Anders Electronics Plc engages in wholesale of electronic and telecommunications equipment and parts. It offers display solutions, embedded solutions, and design services. The company was founded in 1952 and is headquartered in London, the United Kingdom. | Distribution Services |
Selectronic Ltd.
Selectronic Ltd. Electronic Production EquipmentElectronic Technology Selectronic Ltd. manufactures and distributes TFT displays, LED custom display lighting, touch panels, PCB modules, LED lighting and other related products. The company was founded in 1979 and is headquartered in Oxfordshire, the United Kingdom. | Electronic Technology |
Threadneedle Investments Singapore (Pte) Ltd.
Threadneedle Investments Singapore (Pte) Ltd. Investment ManagersFinance Threadneedle Investments Singapore (Pte) Ltd. is an investment management firm headquartered in Singapore. They are a subsidiary of Threadneedle Asset Management Holdings Ltd., ultimately owned by Ameriprise Financial, Inc. (NYSE: AMP) in the US. The firm provides a broad range of actively managed investment strategies and solutions for individual, institutional and corporate clients in Asia. | Finance |
Aventamed DAC
Aventamed DAC Medical SpecialtiesHealth Technology Aventamed DAC manufactures medical devices for surgeries. The company was founded by Olive O''Driscoll and John Vaughan and is headquartered in Bishopstown, Ireland. | Health Technology |
Acuity Insights, Inc.
Acuity Insights, Inc. Other Consumer ServicesConsumer Services Acuity Insights, Inc. provides educational services. The company was founded by Rich Emrich, Kelly Dore, and Harold Reiter in September 2014 and is headquartered in Toronto, Canada. | Consumer Services |
| Front Line Medical Technologies Inc |
